
NeOnc Technologies
Clinical-stage biotech firm focused on intranasal delivery of a novel, purified form of monoterpenes from fruits and plants, alone or with other chemotherapy agents.
Employees
Enterprise value
$208m
Authorizing premium user...
Clinical-stage biotech firm focused on intranasal delivery of a novel, purified form of monoterpenes from fruits and plants, alone or with other chemotherapy agents.